Sanofi/BMS, Drug Prices & Medicare Spending
Sanofi/BMS manufactures 3 drugs tracked by Medicare Part D with total spending of $323.0M.
Sanofi/BMS Drugs, Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Clopidogrel | Clopidogrel Bisulfate | $10.00 | Yes |
| 2 | Plavix | Clopidogrel (brand) | $18.00 | Yes |
| 3 | Irbesartan | Irbesartan | $18.00 | Yes |
Frequently Asked Questions
Sanofi/BMS manufactures 3 drugs tracked by Medicare Part D, with total annual spending of $323.0M.
Plavix (Clopidogrel (brand)) is the most expensive at $18.00 per claim.
3 of 3 Sanofi/BMS drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.
For Sanofi/BMS, the underlying data on this page comes from CMS Medicare Part D Drug Spending data. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.
Every number on this page links back to CMS Medicare Part D Drug Spending data; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for Sanofi/BMS is typically a peer within U.S. prescription drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.
Related Manufacturers
20 drugs, $39.5B Medicare spending
25 drugs, $27.0B Medicare spending
27 drugs, $19.9B Medicare spending
21 drugs, $17.8B Medicare spending
Top prescription drugs by Medicare spending
Drugs losing patent protection soon
Source: CMS Medicare Part D Spending, 2026.